Skip to content

Clinical trials

Terminated Leukemia, Myelomonocytic, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Status: Terminated Country / region: United States Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20043
20054
20068
20076
20086
20095
20105
20121
20131
20142
20161
20173
20185
20191
20205
20212
20223
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated72

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center8
OHSU Knight Cancer Institute6
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
City of Hope Medical Center3
Fred Hutchinson Cancer Center3
Vanderbilt-Ingram Cancer Center3
Alliance for Clinical Trials in Oncology2
Astex Pharmaceuticals, Inc.2
Masonic Cancer Center, University of Minnesota2
National Cancer Institute (NCI)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic72
Myelodysplastic Syndromes57
Leukemia, Myeloid, Acute48
Leukemia34
Leukemia, Lymphocytic, Chronic, B-Cell33
Precursor Cell Lymphoblastic Leukemia-Lymphoma33
Myeloproliferative Disorders32
Multiple Myeloma29
Primary Myelofibrosis29
Lymphoma, Follicular28

Trials

Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.